Supreme Petrochem Ltd

Supreme Petrochem announced that the 36th Annual General Meeting(AGM) of the company will be held on 4 July 2025.Powered by Capital Market - Live

The key equity indices traded limited losses in mid-morning trade, amid mixed global cues. Investor sentiment remained cautious amid signs of escalation in geopolitical tensions between India and Pakistan after the Pahalgam terror attack. Additionally, market could be volatile as the monthly Nifty50 F&O contracts are set to expire today. The Nifty traded below the 24,300 level. Pharma shares witnessed buying demand for fifth consecutive trading sessions. Investors will also closely watch the market's response to India's latest diplomatic and economic measures against Pakistan, announced following Tuesday's terrorist attack in Pahalgam in Jammu & Kashmir, which claimed 26 lives. These measures include the suspension of the Indus Waters Treaty, shutting down the Wagah-Attari border, cancelling visas for Pakistanis, along with other measures. At 11:25 IST, the barometer index, the S&P BSE Sensex shed 210.71 points or 0.25% to 79,912.93. The Nifty 50 index declined 63 points or 0.26% to 24,265.95. In the broader market, the S&P BSE Mid-Cap index fell 0.11% and the S&P BSE Small-Cap index added 0.39%. The market breadth was positive. On the BSE, 2,112 shares rose and 1,536 shares fell. A total of 194 shares were unchanged. Economy: On the macroeconomic front, the World Bank on Wednesday revised its growth outlook for India, trimming its forecast by 0.4 percentage points to 6.3% for the current fiscal year. The revision reflects rising global uncertainty, which the institution warned could dampen growth prospects across South Asia. Buzzing Index: The Nifty Pharma index jumped 1.17% to 21,993.85. The index rallied 5.36% in the five trading sessions. Natco Pharma (up 11.21%), Divis Laboratories (up 5.22%), Zydus Lifesciences (up 2.03%), Lupin (up 1.97%), Ajanta Pharma (up 1.89%), Aurobindo Pharma (up 1.68%), J B Chemicals & Pharmaceuticals (up 1.29%), Dr Reddys Laboratories (up 1.27%), Glenmark Pharmaceuticals (up 1.22%) and Mankind Pharma (up 1.1%) advanced. Stocks in Spotlight: Supreme Petrochem advanced 1.08%. The petrochemical company reported 18.71% decline in standalone net profit to Rs 106.89 crore in Q4 FY25 as against Rs 131.50 crore posted in Q4 FY24. Total revenue from operations shed 1.52% YoY to Rs 1,539.02 crore in the quarter ended 31 March 2025. Tata Consumer Products declined 1.76% after the company's EBITDA margin narrowed by 250 bps to 13.6% in Q4 FY25 as against 16.1% in Q4 FY24, driven by higher input cost in India and international businesses. The company reported a 52.06% jump in consolidated net profit to Rs 407.07 crore in Q4 FY25 as compared with Rs 267.71 crore in Q4 FY24. Revenue from operations jumped 17.35% to Rs 4,608.22 crore in Q4 FY25 as compared with Rs 3926.94 crore in Q4 FY24. Hindustan Unilever (HUL) added 3.88% after the company reported a 3.61% jump in standalone net profit to Rs 2,493 crore in Q4 FY25, compared with Rs 2,406 crore in the corresponding quarter last year. Revenue from operations rose 2.08% to Rs 15,000 crore in Q4 FY25, compared with Rs 14,693 crore in Q4 FY24. Global Market: Asian market traded mixed on Thursday, following gains on Wall Street driven by renewed optimism over potential progress in U.S.-China trade relations. In the latest development, China indicated a willingness to engage in trade talks with the United States. However, it emphasized that it would not participate in negotiations under continued threat of sanctions or tariffs from the U.S. administration. This dual stance contributed to cautious optimism among global investors. In South Korea, advance estimates released Thursday showed that GDP contracted by 0.1% in the first quarter of 2025, signaling potential economic headwinds in the region. On Wall Street, the three major indices closed higher overnight, supported by hopes that trade tensions may ease in the near term. Additionally, President Donald Trump signaled that he does not intend to remove Federal Reserve Chair Jerome Powell, a move that appeared to reassure financial markets. At the close in NYSE, the Dow Jones Industrial Average rose 1.07%, while the S&P 500 index gained 1.67%, and the NASDAQ Composite index added 2.50%. On Thursday, investors will look for quarterly earnings reports from Alphabet, Intel and PepsiCo. On the economic data front, durable gods orders and weekly jobless claims are also due.Powered by Capital Market - Live

Total revenue from operations shed 1.52% YoY to Rs 1,539.02 crore in the quarter ended 31 March 2025. Profit before tax stood at Rs 142.89 crore in Q4 FY25, down 19.07% from Rs 176.57 crore reported in Q4 FY24. Operational EBITDA was at Rs 144.7 crore in the fourth quarter of FY24, registering a de-growth of 17.46% from Rs 175.3 crore reported in Q4 FY24. EBITDA margin reduced to 9.40% in Q4 FY25 as compared to 11.22% recorded in the corresponding quarter previous year. On a full-year basis, the company's standalone net profit increased 12.70% to Rs 390.52 crore on 14.61% jump in revenue to Rs 6,001.60 crore in FY25 over FY24. Meanwhile, the company's board has recommended a final dividend of Rs 7.50 per equity share for the financial year ended 31 March 2025, subject to approval of members in the ensuing annual general meeting (AGM) of the company Supreme Petrochem (SPL) manufactures polystyrene, expandable polystyrene, and extruded polystyrene. It has a polystyrene manufacturing plant at Nagothane in Raigad, Maharashtra. Apart from the primary business of polystyrene and expandable polystyrene production, SPL imports styrene monomer and trades in the domestic market. The counter rose 1.29% to Rs 640.25 on the BSE. Powered by Capital Market - Live

Supreme Petrochem announced that the Board of Directors of the Company at its meeting held on 23 April 2025, inter alia, have recommended the final dividend of Rs 7.5 per equity Share (i.e. 375%) , subject to the approval of the shareholders.Powered by Capital Market - Live

Net profit of Supreme Petrochem declined 18.71% to Rs 106.89 crore in the quarter ended March 2025 as against Rs 131.50 crore during the previous quarter ended March 2024. Sales declined 1.57% to Rs 1533.83 crore in the quarter ended March 2025 as against Rs 1558.22 crore during the previous quarter ended March 2024. For the full year,net profit rose 12.71% to Rs 390.52 crore in the year ended March 2025 as against Rs 346.49 crore during the previous year ended March 2024. Sales rose 14.61% to Rs 6001.60 crore in the year ended March 2025 as against Rs 5236.49 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1533.831558.22 -2 6001.605236.49 15 OPM %9.4311.24 -8.878.91 - PBDT160.36192.54 -17 593.37527.71 12 PBT142.89176.56 -19 525.43468.22 12 NP106.89131.50 -19 390.52346.49 13 Powered by Capital Market - Live

Supreme Petrochem has fixed 04 July 2025 as record date for final dividend of Rs 7.50 per equity share for FY 2024-25. The dividend will be paid on or after 21 July 2025, if approved. Powered by Capital Market - Live

Profit before tax stood at Rs 96.11 crore in Q3 FY25, up 4% from Rs 92.41 crore reported in Q3 FY24. Operational EBITDA was at Rs 99.3 crore in the third quarter of FY24, registering a growth of 4.64% from Rs 94.9 crore reported in Q3 FY24. EBITDA margin reduced to 7.07% in Q3 FY25 as compared to 7.99% recorded in the corresponding quarter previous year. On a nine-month basis, the company's net profit jumped 31.93% to Rs 283.64 crore on 21.51% rise in revenue from operations to Rs 4,484.36 crore in 9M FY24 over 9M FY23. Meanwhile, the first phase of the Mass ABS project with 70,000 TPA capacity under license from Versatis, Italy is likeky to be mechanically compteted by 31 March 2025 with commissioning in the first quarter of financiatyear 2025-26. Supreme Petrochem (SPL) manufactures polystyrene, expandable polystyrene, and extruded polystyrene. It has a polystyrene manufacturing plant at Nagothane in Raigad, Maharashtra. Apart from the primary business of polystyrene and expandable polystyrene production, SPL imports styrene monomer and trades in the domestic market. The scrip rose 0.87% to end at Rs 653.70 on Friday, 18 January 2025. Powered by Capital Market - Live

Net profit of Supreme Petrochem rose 5.44% to Rs 71.35 crore in the quarter ended December 2024 as against Rs 67.67 crore during the previous quarter ended December 2023. Sales rose 18.07% to Rs 1397.17 crore in the quarter ended December 2024 as against Rs 1183.33 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1397.171183.33 18 OPM %7.108.01 - PBDT113.19107.49 5 PBT96.1292.41 4 NP71.3567.67 5 Powered by Capital Market - Live

Supreme Petrochem will hold a meeting of the Board of Directors of the Company on 17 January 2025.Powered by Capital Market - Live

The agency has concurrently reaffirmed the rating on the short-term facilities at 'CRISIL A1+'. CRISIL Ratings stated that the outlook revision factors in expectation of sustenance of healthy operating performance of SPL, going forward, on the back of forthcoming commissioning of acrylonitrile butadiene styrene (ABS) capacity in last quarter of current fiscal, steady growth in sales volume for its key products and benefits from economies of scale which will sustain operating profit at a level much higher than pre-pandemic levels. While operating margin could fluctuate, which is an inherent risk in this business, the company is well placed to absorb these fluctuations given its debt-free balance sheet and strong liquidity position. The financial risk profile is backed by nil debt, strong liquidity and healthy cash accrual. The company is planning capital expenditure (capex) of Rs 350-400 crore annually over fiscals 2025-2027 for setting up a 140,000-tonne capacity for ABS in a phased manner (Phase 1 with 70,000 tonne capacity expected to be commissioned by last quarter of current fiscal), a greenfield project in Haryana and capacity expansions in existing product segments. These expansions will be entirely funded through available liquid surplus and internal accrual. SPL is likely to maintain liquid surplus of Rs 400-500 crore and a debt-free balance sheet over the medium term. The ratings continue to reflect SPL's market leadership in the domestic polystyrene (PS) and expandable polystyrene (EPS) industry, and sound financial risk profile. SPL has a healthy track record of over 25 years in the PS industry and a diversified customer base. The company has a wide product portfolio, with increasing revenue share from value-added products. These strengths are partially offset by susceptibility to volatility in raw material prices. Supreme Petrochem manufactures polystyrene (PS), expandable polystyrene (EPS) compounds of polymers and XPS. It has a manufacturing plant at Nagothane in Raigad, Maharashtra, set up in technical collaboration with ABB Lumus Crest (USA). It also has a manufacturing plant at New Manali Town in Chennai. Furthermore, SPL imports styrene monomer and trades in the domestic market. For the first half of fiscal 2024, the company reported profit after tax (PAT) of Rs 212 crore (Rs 147 crore in the corresponding period of the previous fiscal) on revenue of Rs 3,079 crore (Rs 2,503 crore in the previous fiscal). The scrip fell 2.10% to currently trade at Rs 715.70 on the BSE. Powered by Capital Market - Live